Tag: mRNA
BioAsia 2022: India’s biotech sector stakeholders discuss learnings from pandemic
Normally a vaccine development process takes 6-8 years for research and trials, but path-breaking work has been done in India
Avantor completes acquisition of Masterflex®
The acquisition strengthens Avantor's offering across all bioproduction platforms including monoclonal antibodies (mAbs), cell and gene therapy
India’s vaccine power at UNGA: PM Modi mentions mRNA vaccine for...
Prime Minister Narendra Modi was referred to the mRNA vaccine being developed by Gennova Biopharma during his address at the United Nation General Assembly (UNGA)...............................
India’s first mRNA-based Covid-19 vaccine gets DCGI nod for Phase II...
The trial for India’s first mRNA-based vaccine from Gennova Biopharmaceuticals was found to be safe in Phase I study. Post Drugs Controller General of India approval, Phase II and Phase III trials are to commence in early September, 2021......................
No room for vaccination hesitancy as it’s key to fight COVID-19:...
The bulk of the Indian population should go for vaccination as it is essential to fight the battle against coronavirus....................
COVID-19: India’s own mRNA vaccine set to begin human clinical trials
Indigenous mRNA vaccine candidate supported by Department of Biotechnology has got Drug Controller nod to initiate Human clinical trials........................
Hope for new treatment for Huntington’s disease
The discovery, published in the journal Nucleic Acids Research, opens the way for new approaches to treating the currently untreatable and deadly neurodegenerative disease....